A.49 Toripalimab - nasopharyngeal and oesophageal cancer - EML

Application, expert reviews and public comments

Application

Inclusion of Toripalimab - nasopharyngeal and oesophageal cancer - EML

Expert reviews

Expert Review 1

Expert Review 2

Comments

International Society of Oncology Pharmacy Practitioners

WHO Department Comments

Noncommunicable Diseases

EML Working Groups

EML Cancer Medicines Working Group